Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: A meta-analysis

International Journal of Medical Sciences

Volumn 10, Issue 2, 2013, Pages 198-205

  Zhou, Xue ^a   Du, Jian Lin ^b   Yuan, Jia ^b   Chen, Yun Qing ^b  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Atrial fibrillation; Statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME.; ATRIAL FIBRILLATION; STATINS;

ACUTE CORONARY SYNDROME; ATRIAL FIBRILLATION; ENZYME INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PUBMED; RISK ASSESSMENT;

EID: 84873053638     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5248     Document Type: Article

References (32)

1. Goldberg RJ, Seeley D, Becker RC, et al. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: A community-wide perspective. Am Heart J. 1990;119:996-1001.
2. Pedersen OD, Bagger H, Køber L, et al. on behalf of the TRACE Study group. The occurrence and prognostic significance of atrial fibrillation/ flutter following acute myocardial infarction. Eur Heart J. 1999;20:748-754.
3. Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-974.
4. Pizzetti F, Turazza FM, Franzosi MG, et al. on behalf of the GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86:527-532.
5. Mehta RH, Dabbous OH, Granger CB, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031-6.
6. Lopes RD, Pieper KS, Horton JR, et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart.2008; 94: 867-873.
7. Berton G, Cordiano R, Cucchini F, et al. Atrial fibrillation during acute myocardial infarction: Association with all-cause mortality and sudden death after 7-year of follow-up. Int J Clin Pract.2009; 63: 712-721.
8. Young-Xu Y, Jabbour S, Golderg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003;92:1379-1383.
9. Pellegrini CN, Vittinghoff E, Lin F, et al. Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart. 2009;95: 704-708.
10. Kulik A, Singh JP, Levin R, et al. Association Between Statin Use and the Incidence of Atrial Fibrillation Following Hospitalization for Coronary Artery Disease. Am J Cardiol. 2010;105: 1655-1660.
11. Schwartz GG, Olsson AG, Chaitman B, et al. Effect of intensive statin treatment on the occurrence of atrial fibrillation after acute coronary syndrome: an analysis of the MIRACL trial. Circulation. 2004;110 Suppl:S740.
12. Subramaniam K, Koch CG, Bashour A, et al. Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth. 2008;20:4-11.
13. Virani SS, Nambi V, Razavi M, et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008;155: 541-546.
14. [Internet] Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta- analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
16. Ramani G, Zahid M, Good CB, et al. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol. 2007;100: 404-405.
17. Vedre A, Gurm HS, Froehlich JB, et al; GRACE Investigators. Impact of Prior Statin Therapy on Arrhythmic Events in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol.2009; 104: 1613-7.
18. Danchin N, Fauchier L, Marijon E, et al. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: Data from the FAST-MI register. Heart. 2010;96: 1809-14.
19. Dziewierz A, Siudak Z, Rakowski T, et al. Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively. Cardiol J.2010; 17: 57-64.
20. Ozaydin M, Turker Y, Erdogan D, et al. The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. Int J Cardiol.2010; 141: 147-150.
21. Bang CN, Gislason G, Kober L, et al. Statins reduce risk of new-onset AF after first-time myocardial infarction - A nationwide cohort study. European Heart Journal 32: 625. Eur J Prev Cardiol 2012; [Epub ahead of print].
22. Rahimi K, Emberson J, McGale P, et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 2011; 342:d1250.
23. Miceli A, Fino C, Fiorani B, et al. Effects of Preoperative Statin Treatment on the Incidence of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Surg.2009; 87: 1853-8.
24. Adabag AS, Nelson DB, Bloomfield HE. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J.2007; 154: 1140-1145.
25. Davidenkova EF, Shafron MG. Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis. Klin Med (Mosk).1989; 67: 56-58.
26. Malle E, Marsche G, Panzenboeck U, et al. Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins. Arch Biochem Biophys. 2006; 445: 245-255.
27. Paoletti R, Gotto Jr AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004;109:III20-6.
28. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886.
29. Yao SY, Chu JM, Chen KP, et al. Inflammation in lone atrial fibrillation. Clin Cardiol.2009;32:94-8.
30. Das UN. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essen Fatty Acids. 2001; 65: 37-40.
31. Adam O, Neuberger HR, Böhm M, et al. Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. Circulation.2008; 118:1285-1293.
32. Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation. 2011;124:1107-17.